Bruce Keyt Igm Biosciences, Inc. (IGMS) insider trading activity

IGMS Quotes by TradingView

Bruce Keyt is CHIEF SCIENTIFIC OFFICER of IGM Biosciences, Inc.. Currently has a direct ownership of 242,948 shares of IGMS, which is worth approximately $3.13 Million. The most recent transaction as insider was on Sep 13, 2024, when has been sold 1,487 shares (Common Stock) at a price of $11.54 per share, resulting in proceeds of $17,159. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 243K
0.61% 3M change
75.98% 12M change
Total Value Held $3.13 Million

Bruce Keyt Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 13 2024
SELL
Open market or private sale
$17,159 $11.54 p/Share
1,487 Reduced 0.61%
242,948 Common Stock
Jul 19 2024
BUY
Grant, award, or other acquisition
-
46,666 Added 16.03%
244,435 Common Stock
Jun 14 2024
SELL
Open market or private sale
$8,383 $7.58 p/Share
1,106 Reduced 0.56%
197,769 Common Stock
May 15 2024
BUY
Grant, award, or other acquisition
$15,059 $5.02 p/Share
3,000 Added 1.49%
198,875 Common Stock
Mar 26 2024
BUY
Grant, award, or other acquisition
-
24,019 Added 10.92%
195,875 Common Stock
Mar 14 2024
SELL
Open market or private sale
$18,753 $10.17 p/Share
1,844 Reduced 1.06%
171,856 Common Stock
Mar 13 2024
SELL
Open market or private sale
$20,757 $9.88 p/Share
2,101 Reduced 1.2%
173,700 Common Stock
Mar 12 2024
BUY
Grant, award, or other acquisition
-
46,250 Added 20.83%
175,801 Common Stock
Dec 13 2023
SELL
Open market or private sale
$43,777 $5.78 p/Share
7,574 Reduced 5.52%
129,551 Common Stock
Nov 27 2023
SELL
Open market or private sale
$4,720 $5.06 p/Share
933 Reduced 0.68%
137,125 Common Stock
May 23 2023
SELL
Open market or private sale
$12,432 $12.66 p/Share
982 Reduced 0.71%
138,058 Common Stock
May 15 2023
BUY
Grant, award, or other acquisition
$11,241 $11.71 p/Share
960 Added 0.69%
139,040 Common Stock
Apr 18 2023
BUY
Grant, award, or other acquisition
-
21,126 Added 13.27%
138,080 Common Stock
Apr 04 2023
BUY
Grant, award, or other acquisition
-
26,250 Added 18.33%
116,954 Common Stock
Mar 14 2023
SELL
Open market or private sale
$24,217 $18.73 p/Share
1,293 Reduced 1.41%
90,704 Common Stock
Jan 05 2023
BUY
Exercise of conversion of derivative security
$31,393 $0.93 p/Share
33,756 Added 26.84%
91,997 Common Stock
Dec 16 2022
SELL
Open market or private sale
$102,424 $19.07 p/Share
5,371 Reduced 8.44%
58,241 Common Stock
Dec 14 2022
BUY
Exercise of conversion of derivative security
$23,250 $0.93 p/Share
25,000 Added 28.21%
63,612 Common Stock
Nov 23 2022
SELL
Open market or private sale
$19,013 $21.68 p/Share
877 Reduced 2.22%
38,612 Common Stock
Oct 04 2022
SELL
Open market or private sale
$571,000 $22.84 p/Share
25,000 Reduced 38.77%
39,489 Common Stock
Oct 04 2022
BUY
Exercise of conversion of derivative security
$23,250 $0.93 p/Share
25,000 Added 27.94%
64,489 Common Stock
Sep 08 2022
SELL
Open market or private sale
$199,600 $19.96 p/Share
10,000 Reduced 20.21%
39,489 Common Stock
Sep 08 2022
BUY
Exercise of conversion of derivative security
$9,300 $0.93 p/Share
10,000 Added 16.81%
49,489 Common Stock
Sep 07 2022
SELL
Open market or private sale
$190,400 $19.04 p/Share
10,000 Reduced 20.21%
39,489 Common Stock
Sep 07 2022
BUY
Exercise of conversion of derivative security
$9,300 $0.93 p/Share
10,000 Added 16.81%
49,489 Common Stock
BK

Bruce Keyt

CHIEF SCIENTIFIC OFFICER
Mountain View, CA

Track Institutional and Insider Activities on IGMS

Follow IGM Biosciences, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IGMS shares.

Notify only if

Insider Trading

Get notified when an Igm Biosciences, Inc. insider buys or sells IGMS shares.

Notify only if

News

Receive news related to IGM Biosciences, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on IGMS